Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 04, 2026 16:29 ET | Source: Bragar Eagel & Squire

CAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Capricor (CAPR) To Contact Him Directly To Discuss Their Options If you purchased or...
August 04, 2026 12:47 ET | Source: Bernstein Liebhard LLP

CAPRICOR THERAPEUTICS, INC. (CAPR) INVESTOR ALERT Investors With Large Losses in Capricor Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Capricor Therapeutics Shareholders Between December 17, 2025 and July 6, 2026 - Contact Bernstein Liebhard For More Information Regarding Lawsuit
August 04, 2026 07:45 ET | Source: Robbins Geller Rudman & Dowd LLP

CAPR INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Capricor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

The case alleges Capricor Therapeutics and certain of its top executives made false and/or misleading statements to investors.
August 03, 2026 06:36 ET | Source: Bleichmar Fonti & Auld

CAPR Investigation Notice: Capricor Therapeutics Hit with Securities Fraud Investigation over Clinical Data Misrepresentations – Investors Urged to Contact BFA Law

Capricor Therapeutics Hit with Securities Fraud Investigation over Clinical Data Misrepresentations – Investors Urged to Contact BFA Law
August 02, 2026 12:10 ET | Source: The Rosen Law Firm PA

Capricor Investor News: If You Have Suffered Losses in Capricor Therapeutics Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Aug. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Capricor...
July 31, 2026 06:46 ET | Source: Bleichmar Fonti & Auld

$CAPR Securities: Suffer Losses on Your Capricor Therapeutics Investment? BFA Law Notifies Investors of the Securities Fraud Lawsuit to Recover Losses

Suffer Losses on Your Capricor Therapeutics Investment? BFA Law Notifies Investors of the Securities Fraud Lawsuit to Recover Losses
July 30, 2026 17:25 ET | Source: The Rosen Law Firm PA

Capricor Investor News: If You Have Suffered Losses in Capricor Therapeutics Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Capricor...
July 29, 2026 18:08 ET | Source: Bragar Eagel & Squire

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Capricor Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Capricor (CAPR) To Contact Him Directly To Discuss Their Options If you purchased or...
November 10, 2025 10:16 ET | Source: KUEHN LAW, PLLC

Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Capricor Therapeutics, Inc. (NASDAQ: CAPR)...
October 08, 2025 14:16 ET | Source: Bragar Eagel & Squire

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Capricor allegedly misled investors about its DMD therapy’s FDA approval prospects; an FDA rejection letter citing lack of efficacy data sent shares down.